Professor Tim Eisen is a Medical Oncologist and clinical trialist based at Addenbrooke's Hospital and Cambridge University.

Professor Eisen is interested in developing new treatments for advanced disease, identifying and managing those at risk of disease. His special clinical areas are kidney cancer, lung cancer and melanoma. In kidney cancer and melanoma he has been particularly involved in the development of tyrosine kinase inhibitors as therapeutic agents.

Professor Eisen is a Fellow of the Royal College of Physicians; American Society for Clinical Oncology; European Society for Medical Oncology, a Trustee of Macmillan, a Member & Trustee of Kidney Cancer UK and Medical Advisor to Kidney Cancer Association.

Dr Kate Fife is a Consultant Clinical Oncologist based at Addenbrooke's Hospital in Cambridge. She was appointed in 2001.

Dr Fife trained in medicine at St George’s Hospital in London and went on to train in oncology at the Royal Marsden Hospital. She carried out clinical research in HIV related malignancies whilst a research fellow at Chelsea and Westminster, and Charing Cross Hospitals and completed an MD in angiogenesis related laboratory research in 1998. She completed her oncology training at the Hammersmith Hospital. Subsequently she was a locum Consultant and research fellow at the Sydney Cancer Centre and Sydney Melanoma Unit, carrying out further laboratory and clinical research.

Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic, seeing approximately 130 new patients per year, making it one of the largest specialist centres for this cancer in the UK.  Her other interests are skin malignancies and lung cancer. She treats basal cell and squamous cell cancers of the skin and metastatic melanoma with radiotherapy and patients with rare skin cancers, cutaneous lymphomas and Kaposi’s sarcoma. She is also interested in training and is an educational supervisor.

She is a member of the National Cancer Research Institute Renal Cancer Studies Group and has a frequent attendance and presentations at National and International meetings.